Age-adjusted D-dimer cutoff for the diagnosis of pulmonary embolism: a cost-effectiveness analysis.

CONCLUSIONS: The AADD cutoff results in a clinically non-significant decrease in QALY but important costs reductions. It is a decrementally cost-effective innovation, with a potential of cost savings of >$80 million per year for the United States healthcare system. PMID: 31925875 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31925875?dopt=Abstract

Source: Thrombosis and Haemostasis - January 9, 2020 Category: Hematology Authors: Blondon M, Le Gal G, Meyer G, Righini M, Robert-Ebadi H Tags: J Thromb Haemost Source Type: research